FDA issues advice to women taking hormone replacement therapyBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7416.641-a (Published 18 September 2003) Cite this as: BMJ 2003;327:641
- Deborah Josefson
The US Food and Drug Administration, together with the Department of Health and Human Services and the National Institutes of Health, has launched an educational campaign to inform women about the risks and benefits of post-menopausal hormone replacement therapy (HRT).
The US Congress directed the FDA to develop information material after a number of studies found that HRT was associated with an increased risk of developing certain conditions, including …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial